Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography

Sponsor
Johannes Kepler University of Linz (Other)
Overall Status
Recruiting
CT.gov ID
NCT06074731
Collaborator
(none)
500
1
114
4.4

Study Details

Study Description

Brief Summary

In this pilot study we want to investigate morphological features acquired by the novel image modality and gain information regarding disease pathomechanism, development and future possible influence on disease management for patients affected by those diseases.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: SS-OCT system Plex Elite 9000

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography
Actual Study Start Date :
Jun 1, 2017
Anticipated Primary Completion Date :
Dec 1, 2025
Anticipated Study Completion Date :
Dec 1, 2026

Outcome Measures

Primary Outcome Measures

  1. Morphological changes using Swept Source Optical Coherence Tomography [through study completion, an average of 1 year]

    Morphological changes in retinal diseases provided by Swept Source Optical

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 110 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age between 5 and 110 years

  • Ability to follow instructions during imaging procedure

  • Written Informed consent

Exclusion Criteria:
  • Dementia

  • Inability to follow instructions during imaging procedure

  • Patients who do not give informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria Linz Oberösterreich Austria 4020

Sponsors and Collaborators

  • Johannes Kepler University of Linz

Investigators

  • Principal Investigator: Matthias Bolz, Prof. Dr., Department for Ophthalmology, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Matthias Bolz, Head of Ophthalmology and Optometry, Johannes Kepler University of Linz
ClinicalTrials.gov Identifier:
NCT06074731
Other Study ID Numbers:
  • KUK-Ophthalmology-001
First Posted:
Oct 10, 2023
Last Update Posted:
Oct 10, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 10, 2023